Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study

被引:20
作者
Adachi, YU
Watanabe, K
Higuchi, H
Satoh, T
Vizi, ES
机构
[1] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, H-1450 Budapest, Hungary
[2] Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 3598513, Japan
[3] Self Def Force Cent Hosp, Dept Anesthesia, Setagaya Ku, Tokyo 1548522, Japan
关键词
normobaric oxygen; dopamine; striatum; monoamineoxidase inhibition; (rat);
D O I
10.1016/S0014-2999(01)01074-3
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
In order to explore the effect of normobaric oxygen on the extracellular level of dopamine and its metabolites, oxygen (30, 60 and 90%) was administered to freely moving rats after the animals had been pretreated with either monoamineoxidase (MAO)-A and -B inhibitors (0.1 or 1 mg kg(-1) of clorgyline, 1 or 10 mg kg(-1) of selegiline and 75 mg kg(-1) pargyline) or control solution. The levels of dopamine and its metabolites were monitored in microdialysis samples collected every 20 min and directly applied to an on-line high-performance liquid chromatograph combined with electrochemical detection. Normobaric oxygen inhalation decreased the level of extracellular dopamine and increased that of 3.4-dihydroxyphenylacetic acid (DOPAC) in a concentration-dependent manner. These changes were partly prevented by pre-treatment with low doses of selegiline or clorgyline, i.e. by conditions in which monoamineoxidase-A or -B was inhibited. When both isoforms of monoamineoxidase were inhibited, there was a drastic increase in extracellular concentrations of dopamine and 3-methoxytyramine, and the levels of DOPAC and homovanilic acid (HVA) were very low. These results indicate that the intracellular metabolism of cytoplasmic dopamine is enhanced by normobaric hyperoxia in rat striatum. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 61 条
[1]
Differential regulation of glutamate, aspartate and γ-aminobutyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway [J].
Abarca, J ;
Bustos, G .
NEUROCHEMISTRY INTERNATIONAL, 1999, 35 (01) :19-33
[2]
Adachi Y, 1999, Masui, V48, P960
[3]
Adachi Y, 2000, Masui, V49, P139
[4]
Halothane anesthesia decreases the extracellular level of dopamine in rat striatum: A microdialysis study in vivo [J].
Adachi Y. ;
Uchihashi Y. ;
Watanabe K. ;
Satoh T. .
Journal of Anesthesia, 2000, 14 (2) :82-90
[5]
BALENTINE JD, 1982, LAB INVEST, V47, P286
[6]
Investigation by Parkinson's disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early mild Parkinson's disease: further results of randomised trial and confidential inquiry [J].
Ben-Shlomo, Y ;
Churchyard, A ;
Head, J ;
Hurwitz, B ;
Overstall, P ;
Ockelford, J ;
Lees, AJ .
BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1191-1196
[7]
Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].
Berman, SB ;
Hastings, TG .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137
[8]
Effect of normobaric hyperoxia on two indexes of synaptic function in Fisher 344 rats [J].
Bickford, PC ;
Chadman, K ;
Williams, B ;
Shukitt-Hale, B ;
Holmes, D ;
Taglialatela, G ;
Joseph, J .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :817-824
[9]
Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake [J].
Budygin, EA ;
Gainetdinov, RR ;
Kilpatrick, MR ;
Rayevsky, KS ;
Männistö, PT ;
Wightman, RM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (02) :125-131
[10]
EFFECTS OF SELECTIVE MONOAMINE-OXIDASE INHIBITORS ON THE INVIVO RELEASE AND METABOLISM OF DOPAMINE IN THE RAT STRIATUM [J].
BUTCHER, SP ;
FAIRBROTHER, IS ;
KELLY, JS ;
ARBUTHNOTT, GW .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (03) :981-988